xenoport inc (XNPT:NASDAQ GS)
William J. Rieflin
Consultant and Director, Xenoport, Inc.
|Age||Total Calculated Compensation||This person is connected to 31 board members in 3 different organizations across 3 different industries.|
See Board Relationships
Mr. William J. Rieflin, Bill, has been the Chief Executive Officer of NGM Biopharmaceuticals, Inc. since October 5, 2010. Mr. Rieflin has been a Consultant of Xenoport, Inc., since September 17, 2010. Mr. Rieflin served as the President of Xenoport Inc. since September 2004 and oversees its corporate development, human resources, legal and administrative functions. Mr. Rieflin served as Strategic Advisor at NGM Biopharmaceuticals, Inc. until October 5, 2010. He served ...
3410 Central ExpresswayPhone: 408-616-7200
Santa Clara, California 95051
Board Members Memberships*
Consultant and Director
Chief Executive Officer and Director
Director, Chairman of Audit Committee and Member of Compensation Committee
The University of Chicago Booth School of Business
Stanford University Law school
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Michael S. Anderson||Chief Executive Officer and Director|
Flamel Technologies SA
|G. Kelly Martin||Chief Executive Officer and Executive Director|
Elan Corporation, plc
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Peter Grant||Chief Executive Officer and Executive Director|
|Arun Sawhney B.Com., P.G.D.B.M.||Managing Director, Chief Executive Officer, Executive Director, Member of Shareholders/Investors Grievance & Share Transfer Committee and Member of Science Committee|
Ranbaxy Laboratories Ltd.
|89.2M||Compensation as of Fiscal Year --.|